Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. south korea
  4. lung cancer
Show results for
Products
Services
Software

Companies


Refine by
Locations
Back to All Locations

  • Asia & Middle East
  • South Korea
Brands

  • panamutyper r
  • alphaliquid
  • eutilex
  • geneswell
  • panamutyper
View all brands

Lung Cancer Equipment Supplied In South Korea

8 equipment items found
In South KoreaAvailable In South KoreaNear South Korea

Eutilex - Model EU307(GPC3-IL18) - Hepatocellular Carcinoma and Non-Small Cell Lung Cancer

Eutilex - Model EU307(GPC3-IL18) - Hepatocellular Carcinoma and Non-Small Cell Lung Cancer

Manufactured by:Eutilex Co.,Ltd.   based inSeoul, SOUTH KOREA
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th generation GPC3 CAR-T required than other groups to remove ...
CONTACT SUPPLIER

PANAMutyper R - Model EGFR - Oncology - Liquid Biopsy Kit

PANAMutyper R - Model EGFR - Oncology - Liquid Biopsy Kit

Manufactured by:Panagene Inc.   based inDaejeon, SOUTH KOREA
Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung ...
CONTACT SUPPLIER

PANAMutyper R - Model KRAS - Oncology - Liquid Biopsy Kit

PANAMutyper R - Model KRAS - Oncology - Liquid Biopsy Kit

Manufactured by:Panagene Inc.   based inDaejeon, SOUTH KOREA
KRAS mutation is found in several cancers such as pancreatic cancer, colorectal cancer, lung cancer, biliary tract cancer and thyroid cancer. The existence of KRAS mutations is often related with a prognostic marker to drug response. For example, KRAS mutation is considered a ...
CONTACT SUPPLIER

PANAMutyper R - Model NRAS - Oncology - Liquid Biopsy Kit

PANAMutyper R - Model NRAS - Oncology - Liquid Biopsy Kit

Manufactured by:Panagene Inc.   based inDaejeon, SOUTH KOREA
NRAS mutation is found in several cancers such as melanoma (13~25%), colorectal cancer (1~6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is know that the drug response against colorectal cancer medicine such as Erbitux and Cetuximab decreased and the prognosis ...
CONTACT SUPPLIER

PANAMutyper - Model EML4-ALK - Screening Kit

PANAMutyper - Model EML4-ALK - Screening Kit

Manufactured by:Panagene Inc.   based inDaejeon, SOUTH KOREA
PANAMutyper™ EML4-ALK Screening Kit is the qualitative diagnostic test kit which is able to detect 16 different EML4-ALK fusion genes of tissue from non-small cell lung cancer (NSCLC) patients using peptide nucleic acid (PNA) probes in a real-time PCR system. The PANAMutyper™ EML4-ALK Screening Kit is intended as an aid for screening EML4-ALK ...
CONTACT SUPPLIER

Txinno Bioscience - Model ULK1 - Inhibitor

Txinno Bioscience - Model ULK1 - Inhibitor

Manufactured by:TxinnoBioscience Inc.   based inYongin-si, SOUTH KOREA
RAS GTPase family has 3 members encoding KRAS, HRAS and NRAS proteins which are involved in controlling normal growth signal. RAS GTPases are also well-known oncogenes that drive tumorigenesis when mutation is ...
CONTACT SUPPLIER

GenesWell - Model ddEGFR - Mutation Test Kit

GenesWell - Model ddEGFR - Mutation Test Kit

Manufactured by:GENCURIX   based inGuro-gu, SOUTH KOREA
Chemotherapy drugs have many side effects such as reduction in white blood cells, hair loss, vomiting because they attack rapidly growing cells without separating cancer cells from normal cells. However targeted therapy drugs have less side effects because they detect and attack specific targets that exist only in cancer ...
CONTACT SUPPLIER

AlphaLiquid - Tumor-Agnostic Test

AlphaLiquid - Tumor-Agnostic Test

Manufactured by:IMB Dx, Inc.   based inSeoul, SOUTH KOREA
Tissue specimens are either from surgical resections or biopsies which may raise the risk of bleeding, and infection and further require recovery from the procedure. Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The risk of tissue biopsy is much ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT